C. Keever-Taylor

S. Heimfeld, K. Sullivan, R. Nash, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A new limiting dilution culture system for the detection of T cell subsets in T cell-depleted marrow grafts.

N. Flomenberg, C. Keever-Taylor, Y. Kawanishi, 1996, Journal of hematotherapy.

Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.

R. Truitt, C. Bredeson, C. Keever-Taylor, 2007, Cytotherapy.

Stimulation by means of dendritic cells followed by Epstein–Barr virus‐transformed B cells as antigen‐presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16‐specific cytotoxic T cell responses

D. Margolis, D. Margolis, C. Keever-Taylor, 2007, Clinical and experimental immunology.

It takes a village ( of therapies ) to achieve optimal long-term outcomes for multiple myeloma

B. Sandmaier, J. Dipersio, C. Bollard, 2022 .

N. Flomenberg, L. Baxter‐Lowe, D. Margolis, 1996, British journal of haematology.

Multiple distinct clones may co-exist in different lineages in myelodysplastic syndromes.

C. Chang, Xiaobo Zhou, F. Monzon, 2009, Leukemia research.

Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34+ cell dose

C. Bredeson, D. Margolis, J. Klein, 2001, Bone Marrow Transplantation.

T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients

B. Cohen, S. Rosen, C. Goolsby, 1998, Bone Marrow Transplantation.

Generation of Th1 T Cell Responses Directed to a HLA Class II Restricted Epitope from the Aspergillus f16 Allergen.

V. Kurup, C. Keever-Taylor, B. Davies, 2004 .

The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells

C. Chang, D. Vesole, B. Logan, 2005, Bone Marrow Transplantation.

Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease

P. Hari, M. Pasquini, M. Horowitz, 2018, Haematologica.

Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical course

C. Bredeson, C. Chang, M. Juckett, 2003, Bone Marrow Transplantation.

Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease.

A. Ferber, R. Korngold, N. Flomenberg, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Complement-mediated T-cell depletion of bone marrow: comparison of T10B9.1A-31 and Muromonab-Orthoclone OKT3.

H. Zeng, C. Keever-Taylor, A. Craig, 2001, Cytotherapy.

Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303.

P. Hari, M. Pasquini, R. Soiffer, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Essential requirements for setting up a stem cell processing laboratory

D. Niederwieser, F. Lanza, C. Chabannon, 2014, Bone Marrow Transplantation.

Herpes simplex thymidine kinase gene-transduced donor lymphocyte infusions.

T. Kuzel, C. Link, R. Burt, 2003, Experimental hematology.

Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation

M. Horowitz, N. Flomenberg, D. Margolis, 1997, Bone Marrow Transplantation.

T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin’s lymphoma: clinical and molecular follow-up

M. Hessner, M. Horowitz, D. Vesole, 1998, Bone Marrow Transplantation.

Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen

V. Kurup, C. Keever-Taylor, B. Davies, 2005, Clinical and experimental immunology.

Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.

V. Kurup, C. Keever-Taylor, S. Konings, 2004, Cytotherapy.

Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.

M. Horowitz, D. Vesole, C. Bredeson, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

M. Horowitz, K. Hsu, G. Heller, 2005, Blood.

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial

D. Vesole, D. Weisdorf, B. Blazar, 2003, Bone Marrow Transplantation.

Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303.

P. Hari, M. Pasquini, R. Soiffer, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation.

B. Cohen, F. A. Davis, S. Rosen, 1998, Blood.

Concurrent presence of both patient and donor t(14;18) in a follicular lymphoma patient after undergoing allogeneic BMT: implications for minimal residual disease detection post-transplant

M. Rosenblum, C. Chang, C. Keever-Taylor, 2003, Bone Marrow Transplantation.

Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen

V. Kurup, C. Keever-Taylor, B. Davies, 2005, Clinical and experimental immunology.

Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alt

J. Klein, N. Flomenberg, D. Vesole, 2002, Blood.

Hydroxyethyl starch as a substitute for dextran 40 for thawing peripheral blood progenitor cell products.

P. Hari, J. Kurtzberg, D. Margolis, 2015, Cytotherapy.

The Reality of Critical Reagent Shortages - What to Do When Dextran is not Available

R. Reich-Slotky, C. Keever-Taylor, L. Caballero, 2014 .

Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation

N. Flomenberg, J. Casper, J. Passweg, 1997, Bone Marrow Transplantation.

M. Hessner, M. Horowitz, N. Flomenberg, 1995, Blood.

Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome.

M. Perales, O. Ringdén, H. Lazarus, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease

Bryon D Johnson, J. Verbsky, M. Cairo, 2022, Frontiers in Immunology.

T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.

J. Klein, C. Kabler-Babbitt, M. Hessner, 1999, Blood.

Training practices of cell processing laboratory staff: analysis of a survey by the Alliance for Harmonization of Cellular Therapy Accreditation.

M. Aljurf, I. Slaper-Cortenbach, C. Keever-Taylor, 2015, Cytotherapy.

C. Kabler-Babbitt, M. Hessner, L. Baxter‐Lowe, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

marrow transplantation for chronic myelogenous leukemia graft-versus- leukemia reactivity after T-cell-depleted allogeneic Use of unrelated marrow grafts compensates for reduced

M. Hessner, N. Flomenberg, J. Casper, 2010 .

Partially CD3+-depleted unrelated and haploidentical donor PSCT has favorable GVHD and survival rates in pediatric hematologic malignancy.

D. Monos, D. Teachey, A. Seif, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation.

F. Appelbaum, M. Pasquini, M. Horowitz, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes.

J. Wagner, S. Spellman, M. Setterholm, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Training practices of hematopoietic progenitor cell–apheresis and –cord blood collection staff: analysis of a survey by the Alliance for Harmonisation of Cellular Therapy Accreditation

P. Rebulla, N. Sacchi, J. Sanders, 2014, Transfusion.

Comparison of immune recovery in recipients of unmanipulated vs T-cell-depleted grafts from unrelated donors in a multicenter randomized phase II–III trial (T-cell depletion trial)

J. Wagner, G. Cloud, T. Small, 2010, Bone Marrow Transplantation.

Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.

G. Sandford, D. Margolis, C. Nicolette, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Generation of cytotoxic T-cell lines using overlapping pentadecapeptides derived from conserved regions of the adenovirus hexon protein.

D. Margolis, C. Keever-Taylor, F. Zhu, 2010, The Journal of general virology.

2-31-02 Autologous lymphocyte depleted hematopoietic stem cell transplantation for rapidly progressive multiple sclerosis; minimal toxicity from a cyclophosphamide/total body irradiation/ methylprednisolone conditioning regimen

B. Cohen, D. Stefoski, C. Keever-Taylor, 1997, Journal of the Neurological Sciences.

Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL

D. Margolis, B. Camitta, M. Eapen, 2006, Bone Marrow Transplantation.

CAR-T Cell Production Using the Clinimacs® Prodigy System

P. Hari, R. Orentas, D. Schneider, 2016 .

Hematologic and immunologic evaluation of recombinant human interleukin-6 in patients with advanced malignant disease: evidence for monocyte activation.

S. Ramanujam, E. Borden, R. Truitt, 1996, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Prophylactic Natural Killer Cell Immunotherapy Following HLA-Haploidentical Hematopoietic Cell Transplantation Prevents Relapse and Improves Survival in Patients with High-Risk Hematological Malignancies

S. Heimfeld, P. Hari, R. Storb, 2016 .

Harvesting Hematopoietic Progenitors : “ Please Release Me , Let Me Go ”

K. Ballen, P. McCarthy, P. Mcsweeney, 2022 .

Immune Reconstitution After Allogeneic Transplantation

C. Keever-Taylor, 2008 .

Phase II trial using haploidentical hematopoietic cell transplantation (HCT) followed by donor natural killer (NK) cell infusion and sirolimus maintenance for patients with high-risk solid tumors.

P. Hari, S. Malarkannan, M. Thakar, 2020 .

Donor Natural Killer (NK) Cell Immunotherapy Following Non-Myeloablative HLA-Haploidentical Hematopoietic Cell Transplantation (HCT) Improves Relapse and Progression Free Survival (PFS) in Patients with Hematologic Malignancies

S. Heimfeld, P. Hari, B. Sandmaier, 2016 .

Process control: application to the cell processing laboratory.

C A Keever-Taylor, C. Keever-Taylor, 2000, Cytotherapy.